Form 4 for VTAK Catheter Precision, Inc.
Accepted 2023-03-27 00:00:00 ET · period of report 2023-03-23 · accession 0001654954-23-003615 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-27 | 2023-03-23 | VTAK | Caruso James Joseph | Dir | C - Cnv Deriv | $0.00 | +1,779 | 1,779 | New | $0 |
| D | 2023-03-27 | 2023-03-23 | VTAK | Caruso James Joseph | Dir | C - Cnv Deriv | $0.00 | -1.78 | 7.93 | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-23 | C | A | 1,779 | $0.00 | 1,779 | D | — | — | |
| 2 | Derivative | Series X Convertible Preferred Stock | 2023-03-23 | C | D | 1.78 | $0.00 | 7.93 | D | $0.00 · — to — | 7,932 Common Stock | (F2) Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American. (F3) Series X Convertible Preferred Stock has no expiration date. |